Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting

Journal of Urology

Volumn 155, Issue 5, 1996, Pages 1667-1673

  Moul, Judd W ^a   Douglas, Thomas H ^b   McCarthy, William F ^b   McLeod, David G ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NONE

Author keywords

blacks; prognosis; prostatectomy; prostatic neoplasms; racial stocks

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CAUCASIAN; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0029866379     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66160-3     Document Type: Article

References (36)

1. Lu-Yao, G. L., McLerran, D., Wasson, J. and Wennberg, J. E. for the Prostate Patient Outcomes Research Team: An assessment of radical prostatectomy: time trends, geographic variation and outcomes. J.A.M.A., 269: 2633, 1993.
2. Catalona, W. J. and Bigg, S. W.: Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J. Urol., 143: 538, 1990.
3. Paulson, D. F., Moul, J. W. and Walther, P. J.: Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J. Urol., 144: 1180, 1990.
4. Walsh, P. C., Partin, A. W. and Epstein, J. I.: Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J. Urol., part 2, 152: 1831, 1994.
5. Zincke, H., Oesterling, J. E., Blute, M. L., Bergstralh, E. J., Myers, R. P. and Barrett, D. M.: Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J. Urol., part 2, 152: 1850, 1994.
6. Boring, C. C., Squires, T. S. and Heath, C. W., Jr.: Cancer statistics for African Americans. CA, 42: 7, 1992.
7. Morton, R. A., Jr.: Racial differences in adenocarcinoma of the prostate in North American men. Urology, 44: 637, 1994.
8. Pienta, K. J., Demers, R., Hoff, M., Kau, T. Y., Montie, J. E. and Severson, R. K.: Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tricounty area, 1973 to 1987. Urology, 45: 93, 1995.
9. Powell, I. J., Kumar, A., Montie, J. E., Haas, G. P., Sakr, W., Grignon, D., Heilbrun, L. and Pontes, J. E.: Prognostic factor variations between African American men and Caucasian men with clinical localized prostate carcinoma who underwent radical prostatectomy. J. Urol., part 2, 151: 413A, abstract 744, 1994.
10. Powell, I., Gelfand, D., Parzuchowski, J., Franklin, A. and Montie, J.: Overcoming barriers to early detection in the African American community; (DEED Program: Detroit Education and Early Detection). J. Urol., part 2,151: 291A, abstract 256, 1994.
11. Clark, J. Y. and Thompson, I. M.: Military rank as a measure of socioeconomic status and survival from prostate cancer. South. Med. J., 87: 1141, 1994.
12. Gleason, D. F. and the Veterans Administration Cooperative Urological Research Group: Histological grading and clinical staging of prostatic carcinoma. In: Urologie Pathology: The Prostate. Edited by M. Tannenbaum. Philadelphia: Lea & Febiger, pp. 171-187, 1977.
13. Mostofi, F. K., Sesterhenn, I. A. and Sobin, L. H.: In: International Histologic Classification of Tumors, No. 22, Histological Typing of Prostate Tumors. New York: Waverly, 1980.
14. Ohori, M., Wheeler, T. M. and Scardino, P. T.: The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations. Cancer, 74: 104, 1994.
15. Partin, A. W. and Oesterling, J. E.: The clinical usefulness of prostate specific antigen: update 1994. J. Urol., 152: 1358, 1994.
16. Oesterling, J. E., Suman, V. J., Zincke, H. and Bostwick, D. G.: PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumors. Urol. Clin. N. Amer., 20: 687, 1993.
17. Cox, D. R.: Regression models and life tables. J. Roy. Stat. Soc. B, 34: 187, 1972.
18. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J. Amer. Stat. Ass., 53: 457, 1958.
19. Harris, E. K. and Albert, A.: Survivorship Analysis for Clinical Studies. New York: Marcel Dekker, Inc., 1991.
20. DeGroot, M. H.: Probability and Statistics. Reading, Massachusetts: Addison-Wesley Publishing Co., 1975.
21. Conover, W. J.: Practical Nonparametric Statistics, 2nd ed. New York: John Wiley & Sons, 1980.
22. Agresti, A.: Categorical Data Analysis. New York: John Wiley & Sons, 1990.
23. Moul, J. W., Sesterhenn, I. A., Connelly, R. R., Douglas, T., Srivistava, S., Mostofi, F. K. and McLeod, D. G.: Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. J.A.M.A., 274: 1277, 1995.
24. Ernster, V. L., Selvin, S., Sacks, S. T., Austin, D. F., Brown, S. M. and Winkelstein, W., Jr.: Prostatic cancer: mortality and incidence rates by race and social class. Amer. J. Epidemiol., 107: 311, 1978.
25. Levine, R. L. and Wilchinsky, M.: Adenocarcinoma of the prostate: a comparison of the disease in blacks versus whites. J. Urol., 121: 761, 1979.
26. Dayal, H. H., Polissar, L. and Dahlberg, S.: Race, socioeconomic status, and other prognostic factors for survival from prostate cancer. J. Natl. Cancer Inst., 74: 1001, 1985.
27. Natarajan, N., Murphy, G. P. and Mettlin, C.: Prostate cancer in blacks: an update from the American College of Surgeons' patterns of care studies. J. Surg. Oncol., 40: 232, 1989.
28. Brawn, P. N., Johnson, E. H., Kuhl, D. L., Riggs, M. W., Speights, V. O., Johnson, C. F., III, Pandya, P. P., Lind, M. L. and Bell, N. F.: Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer, 71: 2569, 1993.
29. Sakr, W. A., Haas, G. P., Cassin, B. F., Pontes, J. E. and Crissman, J. D.: The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J. Urol., 150: 379, 1993.
30. Whittemore, A. S., Lele, C., Friedman, G. D., Stamey, T., Vogelman, J. H. and Orentreich, N.: Prostate-specific antigen as predictor of prostate cancer in black men and white men. J. Natl. Cancer Inst., 87: 354, 1995.
31. Ross, R., Bernstein, L., Judd, H., Hanisch, R., Pike, M. and Henderson, B.: Serum testosterone levels in healthy young black and white men. J. Natl. Cancer Inst., 76: 45, 1986.
32. Ellis, L. and Nyborg, H.: Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids, 57: 72, 1992.
33. Ross, R. K., Bernstein, L., Lobo, R. A., Schimizu, H., Stanczyk, F. Z., Pike, M. C. and Henderson, B. E.: 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet, 339: 887, 1992.
34. Whittemore, A. S., Kolonel, L. N., Wu, A. H., John, E. M., Gallagher, R. P., Howe, G. R., Burch, J. D., Hankin, J., Dreon, D. M., West, D. W., Teh, C. and Paffenbarger, R. S.: Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J. Natl. Cancer Inst., 87: 652, 1995.
35. Coetzee, G. A. and Ross, R. K.: Re: prostate cancer and the androgen receptor. Letter to the Editor. J. Natl. Cancer Inst., 86: 872, 1994.
36. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C. and Buttyan, R.: Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765, 1994.